Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System

Completed

Conditions studied: Hemorrhagic Fever

In brief

A multi-site observation study that was conducted a geographically diverse sites across the United States

Key facts

Study ID

NCT07370454

Run by

Cepheid

People needed

408

Starts

2025-01-13

Expected to finish

2025-10-03

Last updated by the study team

2026-01-27

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Capillary and venous whole blood specimens from blood donors who symptomatic for fever lasting ≤ 10 days OR asymptomatic for fever
• Whole blood specimens collected in EDTA specimens collection devices only

You may not qualify if…

• Any whole blood specimens from blood donors vaccinated with a Hemorrhagic Fever live virus vaccine within the past 28 days
• Any whole blood specimen that were previously enrolled
• Any whole blood specimens not collected according to the manufacturer's instructions

Where it is running

• USAMRIID — Frederick, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.